-
Apr 15 2026MSN Labs Disrupts Diabetes Care with SEMABEST: India’s First Fully Integrated Semaglutide Follows Patent Expiry
From API to Pen: MSN Laboratories Challenges Global Giants with…
Read more -
Apr 04 2026Trump’s Tariff Gambit: Pharma & Metals in the Crossfire of Global Trade
Executive Orders That Redefine Trade Boundaries US President Donald Trump…
Read more -
Apr 01 2026Ethical Marketing Under Watch: NPPA & MCI Crack Down
From inducements to integrity: Can India’s pharma industry rebuild trust…
Read more -
Apr 01 2026Vyome Delivers Breakthrough 2025 Performance, Sets Stage for Next Growth Chapter
Vyome is building the world’s premier platform spanning the US-India…
Read more -
Mar 27 2026Pharma Leaders Power Brand Awards – India’s Most Prestigious Healthcare Leadership Platform
The Pharma Leaders Power Brand Awards, the flagship property of…
Read more -
Mar 24 2026Is Plastic Surgery Safe? What Patients Should Know Before Considering It
With cosmetic procedures on the rise globally, experts stress that…
Read more -
Mar 23 2026Iran War Sparks Pharma Shockwaves: India Faces $500 Million Export Hit
Global supply chain turmoil threatens India’s role as the “Pharmacy…
Read more -
Mar 03 2026Pharma Leaders 2026 : Reimagining Healthcare – Powering Trust, Innovation & Global Impact
Network 7 Media Group’s 17th Annual Pharmaceutical Leadership Summit &…
Read more -
Feb 17 2026From Generics to Genius: India’s Pharma Awakens to Global Leadership
At the 17th Annual Healthcare Leadership Summit & Pharma Leaders…
Read more -
Feb 09 2026India–US Trade Deal Secures Lifeline for Affordable Generics – Dr Dilip Surana
Dr Dilip Surana, CMD of Micro Labs Limited, hails tariff…
Read more
Breaking News
- ticket title
- Vyome CEO Venkat Nelabhotla Unveils the ‘Develop, Own, Make, Commercialize’ Roadmap for Global Life Sciences Leadership in Mumbai
- Pharma Titans & Healthcare Visionaries Honoured — Healthcare Super Brand Awards 2026 Redefine Global Standards at Pharma Leaders Annual Awards
- MGM Institute of Health Sciences Honored as Asia’s Most Prestigious Health Sciences & Patient Centric Institution 2026
- The $1.1 Billion Paradox: Inside Emcure’s High-Stakes Legal Warfare, US FDA Scrutiny, and Leadership Exodus
- Why Healthcare in India Needs Urgent Attention?
- Vyome Seals Strategic Pact With Impetis Biosciences, Unlocking a ~$57 Billion Market Horizon
- NCLT Hyderabad Clears Resolution Plan: Beaufond Industries to Acquire Kobo Biotech as Going Concern
- Beaufond Plc Charts European Course: Advanced Negotiations Under Way for Strategic API Supply Alliance with Netherlands Pharmaceutical Group
- The Architects Of Aesthetics: How India’s Iconic Visionaries are Redefining the Global Skincare Map
- MSN Labs Disrupts Diabetes Care with SEMABEST: India’s First Fully Integrated Semaglutide Follows Patent Expiry
